Skip to content

Modification to Olympus Bronchoscopes Bf-40 Series, Bf-240 Series, and Bf-160 Series

by The Olympus Optical Co.

510(k) K023984

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

18 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK023984 Date31 Jan 2003ClearedStatusActive

Recalls

45 recalls · 18 ongoing · FDA

  • 9 recalls, same reason

    • Ongoing Z-0067-2026 FDA Class I initiated 11 Sep 2025
    • Ongoing Z-0058-2026 FDA Class I initiated 11 Sep 2025
    • Ongoing Z-0064-2026 FDA Class I initiated 11 Sep 2025
    • Ongoing Z-0055-2026 FDA Class I initiated 11 Sep 2025
    • Ongoing Z-0059-2026 FDA Class I initiated 11 Sep 2025
    • Ongoing Z-0065-2026 FDA Class I initiated 11 Sep 2025
    • Ongoing Z-0045-2026 FDA Class I initiated 11 Sep 2025
    • Ongoing Z-0054-2026 FDA Class I initiated 11 Sep 2025
    • Ongoing Z-0047-2026 FDA Class I initiated 11 Sep 2025

    Additional IFU updates to provide further clarification on safe and effective use of bronchoscopes when used in conjunction with laser, argon plasma coagulation, and high-frequency therapy equipment.

    • Ongoing Z-0189-2024 FDA Class I initiated 12 Oct 2023

    There is a risk of endobronchial combustion if high-frequency cauterization is performed while supplying oxygen [and/or] the electrode section of the electrosurgical accessory is too close to the distal end of the endoscope.

    • Ongoing Z-0327-2024 FDA Class II initiated 25 Sep 2023

    Channel air drying process was not validated, and that a small percentage of scopes returned to customers after repair had a wet channel. Water remaining in the channel of the endoscopes has the potential for contamination that could lead to the risk of infection

    • Ongoing Z-2490-2023 FDA Class II initiated 27 Jul 2023

    Complaint of endoscope model becoming lodged in the endotracheal tube connector due to diameter being too large.

  • 4 recalls, same reason

    • Ongoing Z-2014-2023 FDA Class I initiated 8 Jun 2023
    • Ongoing Z-2012-2023 FDA Class I initiated 8 Jun 2023
    • Ongoing Z-2011-2023 FDA Class I initiated 8 Jun 2023
    • Ongoing Z-2013-2023 FDA Class I initiated 8 Jun 2023

    There have been complaints of endobronchial combustion during therapeutic laser procedures with the bronchoscope.

  • 2 recalls, same reason

    • Ongoing Z-1047-2022 FDA Class II initiated 8 Mar 2022
    • Ongoing Z-1046-2022 FDA Class II initiated 8 Mar 2022

    Bronchofiberscope Updated instructions on the use of certain chemicals to be used for reprocessing, conditions for ETO gas sterilization, rinsing steps after high-level disinfection, and a recommendation on using sterilization

    • Terminated Z-2497-2021 FDA Class II initiated 17 Aug 2021

    A gluing step was not performed during the manufacturing of the affected device's insertion tube. There is a potential for the insertion tube to develop a leak, which poses an infection control risk.

  • 5 recalls, same reason

    • Terminated Z-2565-2021 FDA Class II initiated 16 Aug 2021
    • Terminated Z-2567-2021 FDA Class II initiated 16 Aug 2021
    • Terminated Z-2568-2021 FDA Class II initiated 16 Aug 2021
    • Terminated Z-2570-2021 FDA Class II initiated 16 Aug 2021
    • Terminated Z-2566-2021 FDA Class II initiated 16 Aug 2021 on shared 510(k) K023984

    The firm is issuing validated, new reprocessing instructions according to the FDA 2015 guidance, "Reprocessing Medical Devices in Health Care Settings: Validation Methods and Labeling."

  • 21 recalls, same reason

    • Terminated Z-3307-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3291-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3312-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3308-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3283-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3286-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3289-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3292-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3284-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3290-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3309-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3300-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3299-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3287-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3294-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3293-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3296-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3298-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3306-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3295-2018 FDA Class II initiated 8 Aug 2018
    • Terminated Z-3305-2018 FDA Class II initiated 8 Aug 2018

    The attachment of non-Olympus accessories to the bronchoscope s instrument channel port may have resulted in more applied force than expected and lead to loosening of the instrument channel port.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
EOQ
Device Class
Class II
Regulation
21 CFR Part 874.4680
Advisory Committee
Ear, Nose, Throat
FDA Decision
SESE Substantially Equivalent

Other devices from The Olympus Optical Co.

See all devices from The Olympus Optical Co. →